A Phase III Randomized, Double-Blind Trial to Evaluate the Efficacy of Uproleselan Administered with Chemotherapy versus Chemotherapy Alone in Patients with Relapsed/Refractory Acute Myeloid Leukemia
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
GlycoMimetics, Inc
Start Date
November 15, 2018
End Date
November 29, 2024
Administered By
Duke Cancer Institute
Awarded By
GlycoMimetics, Inc
Start Date
November 15, 2018
End Date
November 29, 2024